SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIGHINOLFI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.899
EU - Europa 781
AS - Asia 405
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 3.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.896
PL - Polonia 555
SG - Singapore 144
CN - Cina 128
IT - Italia 96
ID - Indonesia 71
VN - Vietnam 52
DE - Germania 39
GB - Regno Unito 31
SE - Svezia 20
AT - Austria 9
NL - Olanda 8
FI - Finlandia 6
HK - Hong Kong 4
BE - Belgio 3
EU - Europa 3
IE - Irlanda 3
CA - Canada 2
FR - Francia 2
LT - Lituania 2
TR - Turchia 2
UA - Ucraina 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
IN - India 1
IQ - Iraq 1
JM - Giamaica 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 3.090
Salva come PNG Salva come JPEG
Città #
Warsaw 555
Fairfield 331
Ashburn 243
Santa Clara 193
Woodbridge 145
Seattle 131
Houston 116
Wilmington 113
Singapore 111
Cambridge 101
Beijing 88
Chandler 87
Jakarta 70
Dong Ket 52
Princeton 46
Ann Arbor 36
San Diego 33
Washington 21
Bremen 20
Ferrara 19
Shanghai 15
London 14
Santa Maria Di Sala 14
Nuremberg 11
Bologna 10
Falls Church 9
Redwood City 9
Los Angeles 7
Milan 7
Padova 7
Vienna 5
Addison 4
Chiswick 4
Helsinki 4
Hong Kong 4
Jacksonville 4
Boardman 3
Brussels 3
Chicago 3
Cordenons 3
Jinan 3
Mountain View 3
New York 3
North Wales 3
Norwalk 3
Tianjin 3
Clifton 2
Des Moines 2
Dublin 2
Frankfurt am Main 2
Haikou 2
Kilburn 2
Lappeenranta 2
Munich 2
Nanjing 2
New Bedfont 2
Piscataway 2
Prescot 2
Rome 2
Verolanuova 2
Augusta 1
Baghdad 1
Ballykisteen 1
Bayrampaşa 1
Bolzano 1
Buffalo 1
Caerano di San Marco 1
Cangzhou 1
Castel Guelfo di Bologna 1
Changsha 1
Codognè 1
Falkenstein 1
Florence 1
Gurgaon 1
Hounslow 1
Izmir 1
Jiaxing 1
Kansas City 1
Kunming 1
La Paz 1
Ladispoli 1
Mesagne 1
Messina 1
Montreal 1
Newark 1
Olomouc 1
Ottawa 1
Pingdingshan 1
Puyang Chengguanzhen 1
Roncegno 1
Rovigo 1
San Francisco 1
Shenzhen 1
Somma Lombardo 1
Stockholm 1
Taipei 1
Tappahannock 1
Tirana 1
Zhengzhou 1
Totale 2.736
Salva come PNG Salva come JPEG
Nome #
Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation 135
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients 103
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 98
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 94
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 94
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 92
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort 91
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 82
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy 82
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 81
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 80
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing 79
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 76
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort * 76
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 76
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 76
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 75
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 75
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 72
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 72
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 71
Disease progression in HIV Late Presenters: The role of HIV clinical indicator diseases prior to HIV diagnosis 71
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 71
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 70
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 70
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 69
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 69
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 69
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort 68
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D study 67
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 67
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 66
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 65
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 64
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 63
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 60
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 55
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 55
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 54
Switching from TDF to TAF or dual therapy (DT)-based regimens in HIV-infected individuals with viral load <= 50 copies/ml: does eGFR matter? 53
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 52
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 48
null 46
COVID-19 in eastern Emilia: an unusual epidemiology in Northern Italy 46
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 32
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 21
IMMUNOSENESCENCE FEATURES ARE PARTIALLY RESTORED BY ANTIRETROVIRAL THERAPY 2
ANTIRETROVIRAL THERAPY RESTORES NAÏVE T CELL FREQUENCIES OC 8 AND FUNCTIONALITY IN PLWH 1
Totale 3.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020407 0 0 0 0 0 0 4 2 174 129 37 61
2020/20211.412 7 90 58 235 208 183 142 116 74 183 19 97
2021/2022339 41 18 2 5 15 44 21 27 16 39 12 99
2022/2023252 47 10 9 11 44 25 10 36 34 2 16 8
2023/2024334 14 27 29 14 46 91 11 7 5 3 2 85
2024/2025467 25 11 115 25 138 140 13 0 0 0 0 0
Totale 3.254